Congratulations to Poclight Biotech and Myanmar partner for signing!
May 10, 2023
On May 8, 2023, we received a foreign customer from Myanmar in a grand ceremony.
During the meeting, both sides had in-depth exchanges and discussions on various aspects of in vitro diagnostics in Myanmar, such as market development, resource support and product advantages, and the customer also shared his opinions and suggestions. After a long time of communication and exchange, we reached a broad consensus and smoothly signed a strategic cooperation agreement, injecting strong momentum for the brand's expansion in Southeast Asia.
During the visit, Myanmar customer have visited our laboratory, production workshop, quality inspection centre, research and development for analyzer and reagent, storage area, etc.; further understanding of our company's development scale, product quality, supply volume and other aspects.
The visit of the Myanmar customer not only strengthened the communication between Poclight Biotech and foreign customers, but also provided strong support and guarantee for the further development of our products. As the global economic integration is accelerating, Poclight Bio is also well prepared to integrate into the international environment. The company always insists on the goal of high quality products, satisfactory service and reasonable price, and effectively grasps all aspects of product production, sales and service.
As a newcomer in the in vitro diagnostic industry, Poclight Biotech has been continuously improving in the areas of technological innovation, product development and core competitiveness since its establishment, and has taken a place in the international market with its own core competenece. In recent years, it has continued to receive wide acclaim from overseas distributors and end-users.